Clinical trials on AI language model use in digestive healthcare
Large language models (LLMs), such as ChatGPT, have rapidly entered healthcare, but strong clinical evidence for their real-world use remains limited. A new study published in Gastroenterology & Endoscopy provides the first overview of randomized controlled trials (RCTs) evaluating LLMs specifically in digestive diseases.
The international research team systematically reviewed published and ongoing RCTs conducted since 2022 and identified only 14 eligible trials worldwide—four published and ten ongoing. Most studies ...